4//SEC Filing
Vu Quan Anh 4
Accession 0001213900-21-064568
CIK 0001690080other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 8:20 AM ET
Size
6.4 KB
Accession
0001213900-21-064568
Insider Transaction Report
Form 4
Vu Quan Anh
COO / Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-08+275,000→ 275,000 totalExercise: $3.95Exp: 2031-12-08→ Common Stock (275,000 underlying)
Holdings
- 8,000
Common Stock
Footnotes (2)
- [F1]The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as COO / Chief Business Officer. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
- [F2]The options vest in 48 equal monthly installments, beginning on the last day of November 2021, and continuing on the last day of each calendar month thereafter, subject to the Reporting Person's continued service to the Company on such vesting dates.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001892297
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 8:20 AM ET
- Size
- 6.4 KB